The instructions below are specifically directed at authors who wish to submit a manuscript to Bereavement Care. For general information, please visit the Publish With Us section of our website.

Contributions to Bereavement Care can be reports of research, innovations in practice and theory, personal experiences or case reports that add something new to our understanding of bereavement. The editors welcome submissions on the needs of people from different cultures, religions and philosophies. Any research reported must be original. All papers will be subjected to review by referees at the discretion of the editorial office.

Bereavement Care considers all manuscripts on the strict condition that they have been submitted only to Bereavement Care and that they have not been published already and not under consideration for publication or in press elsewhere. Authors who fail to adhere to this condition will be charged with all costs that Bereavement Care incurs and their papers will not be published.

Manuscript preparation

• Most of our readers will have completed some form of counselling training and read a basic text on bereavement. Consequently, some understanding of the topic can be assumed, although we try to avoid the use of jargon in order to make the material accessible to readers from a variety of disciplines. Articles should be consistent with the aims and scope of the journal.
• Papers are accepted only in English. UK English spelling and punctuation is preferred. A typical article may be between 2,000-5,000 words (exclusive of figures and references). Papers that greatly exceed this will be critically reviewed with respect to length. Authors should include a word count with their manuscript.
• Manuscripts should be compiled in the following order: title page; abstract; keywords; main text; acknowledgements; appendixes (as appropriate); references; table(s) with caption(s) (on individual pages); figure caption(s) (as a list).
• Abstracts of 100-150 words are required for all papers submitted.
• Each paper should have 4-6 keywords.
• All the authors of a paper should include their full names, affiliations, postal addresses, telephone and fax numbers and email addresses on the cover page of the manuscript. One author should be identified as the Corresponding Author.
• Please supply a short biographical note for each author.
• For all manuscripts non-discriminatory language is mandatory. Sexist or racist terms should not be used.
• Authors must adhere to SI units. Units are not italicised.
• When using a word that is, or is asserted to be, a proprietary term or trade mark, authors must use the symbol ® or TM.

2. Selecting references

Please keep in mind that a long list of citations is not a measure of a paper's academic respectability and that references are not always necessary to support every assertion.

Do include references that:

• cite relevant research in support of a particular assertion or viewpoint
• indicate important sources of further information
• credit originators of major ideas and theories.

Avoid giving references that:

• provide exhaustive lists of previous work on a topic
• assume two or more citations are necessarily more weighty than one
• give a spurious impression of scholarship
• support assertions that are uncontroversial and adequately supported by common sense
• cite only recent evidence on the assumption that it is more up-to-date and therefore more valid than earlier work.
  
• Description of the journal's reference style.

3. Figures

It is in the author's interest to provide figures and illustrations that are of the highest quality possible. Please be sure that all imported scanned material is scanned at the appropriate resolution: 1200 dpi for line art, no less than 600 dpi for grayscale and no less than 300 dpi for colour.

Figures must be saved separate to text. Please do not embed figures in the paper file.

Files should be saved as one of the following formats: TIFF (tagged image file format), JPEG, PostScript or EPS (encapsulated PostScript), and should contain all the necessary font information and the source file of the application (e.g. CorelDraw/Mac, CorelDraw/PC).

All figures must be numbered in the order in which they appear in the paper (e.g. figure 1, figure 2). In multi-part figures, each part should be labelled (e.g. figure 1(a), figure 1(b)).

Figure captions must be saved separately, as part of the file containing the complete text of the paper, and numbered correspondingly.

The filename for a graphic should be descriptive of the graphic: e.g. Figure1, Figure2a.

4. Colour

Authors of accepted papers who propose publishing figures in colour in the print version should consult Taylor & Francis at proof stage to agree a financial contribution to colour reproduction costs. Colour figures that appear in black-and-white in the print edition of the Journal will appear in colour in the online edition, assuming colour originals are supplied.

5. Reproduction of copyright material

As an author, you are required to secure permission if you want to reproduce any figure, table, or extract from the text of another source. This applies to direct reproduction as well as "derivative reproduction" (where you have created a new figure or table which derives substantially from a copyrighted source). For further information and FAQs, please see http://journalauthors.tandf.co.uk/preparation/permission.asp. This applies to direct reproduction as well as ‘derivative reproduction', where the contributor has created a new figure or table that derives substantially from a copyrighted source. Authors are themselves responsible for the payment of any permission fees required by the copyright owner. Copies of permission letters should be sent with the manuscript on submission to the editor(s).

• Copyright permission letter template

6. Informed consent

Manuscripts must include a statement that informed consent was obtained from participants in case studies. Authors should protect client anonymity by avoiding the use of clients' names or initials, hospital number, or other identifying information.

7. Code of experimental ethics and practice and confidentiality

Contributors are required to follow the procedures in force in their countries which govern the ethics of work conducted with human or animal subjects. The Code of Ethics of the World Medical Association (Declaration of Helsinki) represents a minimal requirement.

For human subjects or patients, describe their characteristics. For human participants in a research survey, secure the consent for data and other material - verbatim quotations from interviews etc - to be used. Specific permission for any facial photographs is required. A letter of consent must accompany any photographs in which the possibility of identification exists. It is not sufficient to cover the eyes to mask identity.

It is your responsibility to ensure that the confidentiality of patients is maintained. All clinical material used in your article must be disguised so that it is not recognisable by a third party. Where possible and appropriate, the permission of the patient should be obtained. Authors are invited to discuss these matters with the editor if they wish.

8. Drug names

Generic rather than trade names of drugs should be used, although trade names may be mentioned in parentheses in the first text reference to the drug.

9. Competing financial interests

A competing interest exists when your interpretation or presentation of information may be influenced by your personal or financial relationship with other people or organisations. Authors should disclose all financial and non-financial competing interests.

Authors are required to complete a declaration of competing interests and submit it together with the manuscript. All competing interests that are declared will be listed at the end of published articles. Where an author gives no competing interests, the listing will read 'The author(s) declare that they have no competing interests'. Please consider the following questions:

1. In the past five years have you received reimbursements, fees, funding, or salary from an organisation that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? Is such an organisation financing this manuscript? If so, please specify.

2. Do you hold any stocks or shares in an organisation that may in any way gain or lose financially from the publication of this manuscript, either now or in the future? If so, please specify.

3. Do you hold or are you currently applying for any patents relating to the content of the manuscript? Have you received reimbursements, fees, funding, or salary from an organisation that holds or has applied for patents relating to the content of the manuscript? If so, please specify.

4. Do you have any other financial competing interests? If so, please specify.

If you are unsure as to whether you, or one of your co-authors, has a competing interest, please discuss it with the editorial office.

10. Affirmation of authorship

All authors are expected to have made substantive intellectual contributions to, and to have been involved in drafting or revising the manuscript. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Acquisition of funding, collection of data, or general supervision of the research group, alone, does not justify authorship. With the submission of a manuscript, it is assumed that all authors have read and approved the final manuscript. 

11. Acknowledgements

All contributors who do not meet the above criteria for authorship should be listed in an acknowledgements section. Examples of those who might be acknowledged include those who provided general, technical, or writing assistance. Acknowledgement of funding/grants are also included in this section.

Manuscript submission

Papers for consideration should be sent to the managing editor, Catherine Jackson, at: catherine.jackson@cruse.org.uk.

Authors are encouraged to submit manuscripts electronically. Electronic submissions should be sent as email attachments using a standard word processing program. If email submission is not possible, please send an electronic version on disk to the following address:

Catherine Jackson
Managing editor
Bereavement Care
Cruse Bereavement Care
PO Box 800
Richmond
Surrey TW9 1RG
UK

Email: catherine.jackson@cruse.org.uk
Tel (direct line): +44 (0)20 8939 9543, fax: +44 (0)20 8940 1671

Copyright and authors' rights

It is a condition of publication that authors assign copyright or license the publication rights, including abstracts, to Cruse Bereavement Care. This enables us to ensure full copyright protection and to disseminate the article, and of course the journal, to the widest possible readership, in print and electronic formats as appropriate. Authors retain many rights under the Taylor & Francis rights policies, which can be found at http://www.informaworld.com/authors_journals_copyright_position. Authors are themselves responsible for obtaining permission to reproduce copyright material from other sources.

Exceptions are made for Government employees whose policies require that copyright cannot be transferred to other parties. We ask that a signed statement to this effect is submitted when returning proofs for accepted papers.

Reprints

Corresponding authors can receive 25 free reprints, free online access to their article through our website (http://www.informaworld.com/) and a complimentary copy of the issue containing their article. Complimentary reprints are available through Rightslink® and additional reprints can be ordered through Rightslink® when proofs are received. If you have any queries, please contact our reprints department at reprints@tandf.co.uk.

Page charges

There are no page charges to individuals or institutions.